BiBBInstruments’ CEO to BioStock: “Agreements with distribution partners will be key to commercial success”
BiBB kicks off 2025 with a commercial breakthrough, as EndoDrill GI is now being used by its first paying customer. With higher-quality tissue samples compared to conventional technology and a bolstered cash position, the Lund-based company is now fully focused on continuing to establish the product and securing agreements with global distribution partners.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se